Rush University Medical Center

CEL-SCI receives $225,000 NIH research grant

Wednesday, July 16, 2014

CEL-SCI has been awarded a phase I Small Business Innovation Research (SBIR) grant for $225,000 from the National Institute of Arthritis Muscoskeletal and Skin Diseases (NIAMS), part of the NIH. The grant will fund the further development of CEL-SCI’s LEAPS technology as a potential treatment for rheumatoid arthritis (RA), an autoimmune disease of the joints. According to Visiongain, the world RA drug market will generate revenues of $38.5 billion in 2017.

[Read More]

Chicago Hospitals awarded NIH grant to accelerate stroke research, treatments

Friday, November 22, 2013

A new network dedicated to advancing research and therapies for stroke is forming in Chicago after receiving $2 million in grants from the NIH. The Chicago Stroke Trials Consortium is a partnership among Northwestern Medicine, Ann and Robert H. Lurie Children’s Hospital of Chicago, John H. Stroger Jr. Hospital of Cook County, Loyola University Medical Center, Rehabilitation Institute of Chicago, Rush University Medical Center and University of Chicago Medicine. It will build an infrastructure to support clinical trials for stroke prevention, treatment and recovery. Northwestern University will be the regional coordinating center for the consortium and administer the project over the next five years.

[Read More]